Neoplasms Metastasis Completed Phase 1 Trials for Dacomitinib (DB11963)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00728390A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 WeeksTreatment